111.78MMarket Cap-0.85P/E (TTM)
8.570High7.730Low500.89KVolume8.050Open8.050Pre Close4.16MTurnover27.72%Turnover RatioLossP/E (Static)13.34MShares19.99952wk High0.85P/B15.14MFloat Cap7.73052wk Low--Dividend TTM1.81MShs Float171.799Historical High--Div YieldTTM10.44%Amplitude7.730Historical Low8.315Avg Price1Lot Size
OnKure Therapeutics Stock Forum
Onkure Therapeutics Inc - Oki-219 Well Tolerated With No Hyperglycemia and Only Grade 1 Traes
SC 13G: Statement of acquisition of beneficial ownership by individuals-Kenneth Griffin(9.9%),Citadel Advisors LLC(9.8%), etc.
SEC 17:29
SC 13G: Statement of acquisition of beneficial ownership by individuals-Cormorant Asset Management, LP(14.98%),Bihua Chen(14.98%), etc.
SEC 16:24
SC 13G: Statement of acquisition of beneficial ownership by individuals-Samsara BioCapital, L...
No comment yet